US Broker Ratings

Pulse Biosciences, Inc. (PLSE) Stock Analysis: A Healthcare Innovator with 66% Potential Upside

Investors with a keen interest in the healthcare sector may find Pulse Biosciences, Inc. (NASDAQ: PLSE) an intriguing prospect. The company, known for its pioneering work in bioelectric medicine, presents..

BioLife Solutions, Inc. (BLFS) Investor Outlook: Analyst Ratings Indicate a 26% Potential Upside

BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the healthcare sector, is making waves in the medical instruments and supplies industry. Based in Bothell, Washington, this innovative company is..

Ardent Health, Inc. (ARDT) Stock Analysis: Unveiling a Potential 58.8% Upside for Healthcare Investors

Ardent Health, Inc. (ARDT) is a noteworthy player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Brentwood, Tennessee, the company operates an extensive network of..

Viking Therapeutics, Inc. (VKTX) Stock Report: A 170% Potential Upside Awaits in the Biotech Sector

Viking Therapeutics, Inc. (NASDAQ: VKTX), a San Diego-based biotechnology company, has captured the attention of investors with its ambitious pipeline and a remarkable potential upside of 170.30%. Specializing in developing..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: A 66.93% Potential Upside Awaits Investors

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a key player in the biotechnology sector, is gaining the attention of investors with its promising therapeutic developments and substantial growth potential. With a market..

Veracyte, Inc. (VCYT) Stock Analysis: Evaluating Growth Potential in the Diagnostics Sector

Veracyte, Inc. (NASDAQ: VCYT) is a noteworthy player in the healthcare sector, specifically in diagnostics and research. With a market capitalization of $3.67 billion, Veracyte has carved out a niche..

Kestra Medical Technologies (KMTS) Stock Report: Revenue Growth Soars Amidst Healthcare Innovation

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), a promising player in the healthcare sector, is turning heads with its impressive revenue growth and innovative solutions in the realm of cardiovascular disease..

LivaNova PLC (LIVN) Stock Analysis: A Promising Upside with Strategic Neuromodulation Focus

LivaNova PLC (NASDAQ: LIVN) has been steadily carving out a niche in the healthcare sector with its innovative medical devices tailored for neurological and cardiac conditions. With a market capitalization..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: A Promising Biotech with a 20.65% Return on Equity

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a key player in the biotechnology industry, continues to capture investor attention with its strategic focus on addressing unmet medical needs in autoimmune diseases. With..

Innoviva, Inc. (INVA) Stock Analysis: A 52% Upside Potential and Strategic Partnerships in Focus

Innoviva, Inc. (NASDAQ: INVA) is a name that has been making waves in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $1.58 billion, this U.S.-based..

Vera Therapeutics, Inc. (VERA) Stock Analysis: A 90% Potential Upside in the Biotech Sector

For investors seeking opportunities within the biotechnology sector, Vera Therapeutics, Inc. (NASDAQ: VERA) presents an intriguing proposition, particularly with its impressive potential upside of 90.44%. Based in Brisbane, California, this..

PROCEPT BioRobotics (PRCT) Investor Outlook: Exploring a 71% Potential Upside in the Healthcare Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a leading innovator in the medical devices industry, is capturing investor attention with its significant growth potential, underscored by an impressive 71% potential upside from..

Alvotech (ALVO) Stock Analysis: A Look at the 445% Potential Upside in the Healthcare Sector

Alvotech (NASDAQ: ALVO), a burgeoning player in the specialty and generic drug manufacturing industry, is capturing investor attention with its substantial potential upside. Based in Luxembourg, this healthcare company is..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring a 145% Potential Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is making waves in the biopharmaceutical landscape with its strategic focus on rare and ultra-rare genetic diseases. Headquartered in Novato, California, this biotechnology company has..

Centessa Pharmaceuticals (CNTA) Stock Analysis: 30% Upside Potential Amid Robust Buy Ratings

Centessa Pharmaceuticals plc (CNTA), a clinical-stage biotechnology company based in the United Kingdom, is gaining significant attention from investors, driven by its promising drug pipeline and strong analyst ratings. With..

SS Innovations International (SSII) Stock Analysis: A Healthcare Pioneer with Astonishing 192.5% Revenue Growth

For investors with a keen eye on the healthcare sector, SS Innovations International (SSII) presents a compelling opportunity. This India-based medical devices company has not only captured attention with its..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Navigating a 8.43% Potential Upside Amidst Market Challenges

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a prominent player in the healthcare sector specializing in medical devices, has been on the radar of many investors due to its innovative solutions..

Artivion, Inc. (AORT) Stock Analysis: Investor Insight into a 12.84% Potential Upside in the Medical Devices Sector

Artivion, Inc. (NASDAQ: AORT), a prominent player in the medical devices industry, presents an intriguing investment opportunity with a potential upside of 12.84%. With a market capitalization of $2.17 billion..

Premier, Inc. (PINC) Stock Analysis: Navigating Health Information Services with a 2.97% Dividend Yield

Premier, Inc. (NASDAQ: PINC) stands at the crossroads of healthcare improvement and technological innovation, offering a compelling proposition for investors interested in the health information services industry. Based in Charlotte,..

Surgery Partners, Inc. (SGRY) Investor Outlook: Targeting a 50% Upside with Strong Analyst Support

Surgery Partners, Inc. (NASDAQ: SGRY), a prominent player in the U.S. healthcare sector, operates a comprehensive network of surgical facilities and ancillary services, making it a significant entity in the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds